• Groupe canadien de recherche en soins intensifs
    Le Groupe canadien de recherche en soins intensifs (CCCTG) est un groupe collaboratif voué à la poursuite de l’excellence et à l’avancement de la recherche en soins intensifs au Canada.
  • Groupe canadien de recherche en soins intensifs
    Plus de 30 programmes de recherche sont en cours au CCCTG et plus de 100 articles évalués par les pairs ont été publiés, toujours avec répercussions directes sur la pratique clinique en soins intensifs.
  • Groupe canadien de recherche en soins intensifs
    Le Groupe canadien de recherche en soins intensifs (CCCTG) est un organisme national de plus 300 membres intéressés à la recherche sur la prise en charge des patients gravement malades.
  • Groupe canadien de recherche en soins intensifs
    Le soutien du CCCTG indique son engagement formel à s’assurer que la recherche sera entreprise avec rigueur et éthique et communiquée en temps opportun, de manière efficace.

Standard Operating Procedures Clinical Protocol Ib Blood Sample Collection - PLASMA

TRADUCTION EN FRANÇAIS À VENIR

The main objective of the Canadian Critical Care Research Coordinators Group (CCCRCG) is to create networking opportunities and foster local and national collaboration between Critical Care Research Coordinators.

** NOTE: The following procedure is to be performed wearing laboratory coat, gloves, eye protection, and mask.
 
 
 

PRINCIPLE

Arterial or mixed venous blood will be collected from patients at the indicated time points following randomization.
 
The collection of blood should be obtained from an existing arterial or venous line, or by venipuncture (with a 20 gauge needle or larger), and should be performed by someone experienced in the technique and familiar with infectious precautions. 
 
The use of pneumatic tube system is not recommended since it can activate white blood cells and promote unwanted release of mediators.
 
Processing of the blood should be done as soon as possible after collection in order to prevent the unwanted released of mediators caused by dying cells.
 
Specimen Collection & Handling
1.For each patient, label two 15mL polystyrene collection tubes containing the following:
 
•Tube #1 contains 360μL of sterile trisodium citrate (= “CIT” tube)
 
•Tube #2 contains 360μL of sterile trisodium citrate + 80μl of 1M sterile benzamidine (=“CIT/BZ” tube)
 
** Please note that the sterile trisodium citrate can be obtained from the blue-topped Becton Dickinson vacutainer tubes (BD cat. No.366415). Each vacutainer tube should contain about 500μl of trisodium citrate, but the actual amount that can be removed is closer to 450μL. 
 
2.Draw 2 tubes of 4mL each of blood. IMMEDIATELY transfer the content of one tube into the “CIT” tube and the content of the other tube into the “CIT/BZ” tube. 
 
3.In laboratory, invert the tubes once to mix. Centrifuge at 1700 x g (calculate the speed in rpm taking into account the size of your rotor) for 10 minutes at 4 C with brake off, in a horizontal, swinging bucket centrifuge. 
 
4.Using a plastic transfer pipette, transfer each plasma into 8 cryogenic freezing tubes (ie. 16 cryogenic freezing tubes in total for each patient). 
 
5.Write either “CIT” or “CIT/BZ” on the tops of the cryogenic freezing tubes, and also write the patient ID number and the “day” (for example, “J1, Day 1").
 
6.Store the plasma samples in a -80oC freezer in cardboard boxes or in Ziploc baggies (use one Ziploc bag per patient day).
 
Special Note 1.1: only collect the plasma fraction to within 0.2mL of the interface layer. Note that after centrifugation you should have approximately 2mL of supernatant per tube so transfer only approximately 1.5mL of plasma.
 
Special Note 1.2: Processing and handling of Blood for analysis – please remember endotoxin is ubiquitous and can change expression of all mediators being assayed.